Literature DB >> 30031775

Pre-established Chromatin Interactions Mediate the Genomic Response to Glucocorticoids.

Anthony M D'Ippolito1, Ian C McDowell2, Alejandro Barrera3, Linda K Hong4, Sarah M Leichter5, Luke C Bartelt5, Christopher M Vockley3, William H Majoros2, Alexias Safi4, Lingyun Song4, Charles A Gersbach6, Gregory E Crawford7, Timothy E Reddy8.   

Abstract

The glucocorticoid receptor (GR) is a hormone-inducible transcription factor involved in metabolic and anti-inflammatory gene expression responses. To investigate what controls interactions between GR binding sites and their target genes, we used in situ Hi-C to generate high-resolution, genome-wide maps of chromatin interactions before and after glucocorticoid treatment. We found that GR binding to the genome typically does not cause new chromatin interactions to target genes but instead acts through chromatin interactions that already exist prior to hormone treatment. Both glucocorticoid-induced and glucocorticoid-repressed genes increased interactions with distal GR binding sites. In addition, while glucocorticoid-induced genes increased interactions with transcriptionally active chromosome compartments, glucocorticoid-repressed genes increased interactions with transcriptionally silent compartments. Lastly, while the architectural DNA-binding proteins CTCF and RAD21 were bound to most chromatin interactions, we found that glucocorticoid-responsive chromatin interactions were depleted for CTCF binding but enriched for RAD21. Together, these findings offer new insights into the mechanisms underlying GC-mediated gene activation and repression.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  DNA looping; GR; TAD; chromatin conformation; chromatin loop; chromosome compartment; enhancer; glucocorticoid receptor; hi-c; transcriptional regulation

Mesh:

Substances:

Year:  2018        PMID: 30031775     DOI: 10.1016/j.cels.2018.06.007

Source DB:  PubMed          Journal:  Cell Syst        ISSN: 2405-4712            Impact factor:   10.304


  25 in total

Review 1.  CRISPR technologies for precise epigenome editing.

Authors:  Muneaki Nakamura; Yuchen Gao; Antonia A Dominguez; Lei S Qi
Journal:  Nat Cell Biol       Date:  2021-01-08       Impact factor: 28.824

2.  Intrinsic Dynamics of a Human Gene Reveal the Basis of Expression Heterogeneity.

Authors:  Joseph Rodriguez; Gang Ren; Christopher R Day; Keji Zhao; Carson C Chow; Daniel R Larson
Journal:  Cell       Date:  2018-12-13       Impact factor: 41.582

Review 3.  The next generation of CRISPR-Cas technologies and applications.

Authors:  Adrian Pickar-Oliver; Charles A Gersbach
Journal:  Nat Rev Mol Cell Biol       Date:  2019-08       Impact factor: 94.444

Review 4.  Function and regulation of chromatin insulators in dynamic genome organization.

Authors:  Dahong Chen; Elissa P Lei
Journal:  Curr Opin Cell Biol       Date:  2019-03-12       Impact factor: 8.382

5.  Ep300 sequestration to functionally distinct glucocorticoid receptor binding loci underlie rapid gene activation and repression.

Authors:  Avital Sarusi Portuguez; Ivana Grbesa; Moran Tal; Rachel Deitch; Dana Raz; Limor Kliker; Ran Weismann; Michal Schwartz; Olga Loza; Leslie Cohen; Libi Marchenkov-Flam; Myong-Hee Sung; Tommy Kaplan; Ofir Hakim
Journal:  Nucleic Acids Res       Date:  2022-06-17       Impact factor: 19.160

6.  H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility.

Authors:  Claudia Giambartolomei; Ji-Heui Seo; Tommer Schwarz; Malika Kumar Freund; Ruth Dolly Johnson; Sandor Spisak; Sylvan C Baca; Alexander Gusev; Nicholas Mancuso; Bogdan Pasaniuc; Matthew L Freedman
Journal:  Am J Hum Genet       Date:  2021-11-24       Impact factor: 11.043

7.  Glucocorticoid receptor recruits to enhancers and drives activation by motif-directed binding.

Authors:  Ian C McDowell; Alejandro Barrera; Anthony M D'Ippolito; Christopher M Vockley; Linda K Hong; Sarah M Leichter; Luke C Bartelt; William H Majoros; Lingyun Song; Alexias Safi; D Dewran Koçak; Charles A Gersbach; Alexander J Hartemink; Gregory E Crawford; Barbara E Engelhardt; Timothy E Reddy
Journal:  Genome Res       Date:  2018-08-10       Impact factor: 9.043

8.  Human genome-wide measurement of drug-responsive regulatory activity.

Authors:  Graham D Johnson; Alejandro Barrera; Ian C McDowell; Anthony M D'Ippolito; William H Majoros; Christopher M Vockley; Xingyan Wang; Andrew S Allen; Timothy E Reddy
Journal:  Nat Commun       Date:  2018-12-21       Impact factor: 14.919

Review 9.  Insights into glucocorticoid responses derived from omics studies.

Authors:  Mengyuan Kan; Blanca E Himes
Journal:  Pharmacol Ther       Date:  2020-09-08       Impact factor: 12.310

10.  Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer.

Authors:  Stefan Prekovic; Karianne Schuurman; Isabel Mayayo-Peralta; Anna G Manjón; Mark Buijs; Selçuk Yavuz; Max D Wellenstein; Alejandro Barrera; Kim Monkhorst; Anne Huber; Ben Morris; Cor Lieftink; Theofilos Chalkiadakis; Ferhat Alkan; Joana Silva; Balázs Győrffy; Liesbeth Hoekman; Bram van den Broek; Hans Teunissen; Donna O Debets; Tesa Severson; Jos Jonkers; Timothy Reddy; Karin E de Visser; William Faller; Roderick Beijersbergen; Maarten Altelaar; Elzo de Wit; Rene Medema; Wilbert Zwart
Journal:  Nat Commun       Date:  2021-07-16       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.